After acquiring a series of mutations, starting with KRAS, PanIN develops into Pancreatic Ductal Adenocarcinoma (PDAC) which makes up 90% of the pancreatic cancer cases [86], as shown in Fig. 4. This evidence concerns the gene KRAS and pancreatic neoplasm.